In The News

You are here

Dr. Souweidane’s Phase 1 Trial Findings Published in Lancet Oncology

Mark M Souweidane, MD, Weill Cornell Medicine

Today, the peer-reviewed journal Lancet Oncology published the highly anticipated results of Dr. Mark Souweidane’s first-ever dose escalation study using convection-enhanced delivery (CED) in patients with diffuse intrinsic pontine glioma (DIPG). The milestone Phase I clinical trial, which investigated the safety of using CED to bypass the blood-brain barrier and administer a drug directly to a brain stem tumor site, resulted in no serious adverse effects and no dose-limiting toxicity; researchers conclude that the technique is safe to use in children.

Dr. Souweidane Talks About DIPG on The Lancet Oncology

Dr. Mark Souweidane - Weill Cornell Medicine

Dr. Souweidane joins The Lancet Oncology to discuss his dose-escalation study, assessing a convection-enhanced delivery for diffuse intrinsic pontine glioma.


Dr. Kaplitt Talks About Focused Ultrasound on CoreBrain Journal

Michael Kaplitt, MD, PhD, Weill Cornell Medicine

In this second part of a series on Essential Tremor, Dr. Kaplitt talks about using high-intensity focused ultrasound to relieve essential tremor in a patient on CoreBrain Journal.

2018 Residency Graduation Celebrated; New Residents Welcomed

Drs. Peter Morgenstern, Philip E. Stieg, and Brenton Pennicooke

Peter Morgenstern, M.D., is continuing on to Seattle Children’s Hospital to complete a one-year pediatric neurosurgery fellowship; Dr. Brenton Pennicooke will spend his final year of training here at Weill Cornell Medicine in an enfolded fellowship in spine research.

2018 Neurosurgery Softball Tournament

As they do each year, on Saturday, June 9, 2018, the neurosurgeons of Weill Cornell Medicine participated in the annual Neurosurgery Charity Softball Tournament in Central Park. Founded in 2004, the tournament raises funds for brain tumor research.